United States · Bill · HR
H.R. 5122 (114th)
To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Introduced
29 April 2016
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
This bill prohibits the Department of Health and Human Services from taking any further action on a proposed rule to change how Medicare pays for certain drugs that are typically not self-administered (such as some intravenous medications and chemotherapy drugs).
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 29 April 2016
Introduced in House (PDF)
Introduced in House · EN · 29 April 2016
Introduced in House
summary · EN · 29 April 2016
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/house-bill/5122
- Open data entity: https://api.congress.gov/v3/bill/114/hr/5122